09 November, 2026

Company Spotlight
Abbott and Novo broaden access to semaglutide for advanced diabetes care across Asia Pacific

Abbott, the global healthcare leader, and Novo, a global leader in treatments for serious chronic diseases, have announc...Read more

- 06 November 2026 News

Company Spotlight
Japan's Nxera Pharma inks agreement worth $1.47 B with AbbVie for IBD drug

Japan-based Nxera Pharma has announced that its subsidiary, Nxera Pharma UK, has entered into an exclusive global licens...Read more

- 06 November 2026 News


World
Korea's IVI supports Minapharm for development of Bundibugyo ebolavirus vaccine


South Korea-based International Vaccine Institute (IVI) has joined Bayer AG and the Coalition for Epidemic Preparedness ...Read more

- 06 November 2026 News


Vietnam
NCCN and Viet Nam National Cancer Hospital expand collaboration to advance cancer care resources in Vietnam


The National Comprehensive Cancer Network® (NCCN®) has announced the signing of a new agreement with the Vi...Read more

- 06 November 2026 News



Company Spotlight
Boehringer Ingelheim and Sino Biopharma advance next-gen cancer therapies with $7 B deal


Boehringer Ingelheim, headquartered in Germany, and China-based Sino Biopharmaceutical (together with its subsidiaries, ...Read more

- 06 November 2026 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.